Intracellular trafficking and interactions of the HIV-1 Tat protein

Virology

Volumn 252, Issue 1, 1998, Pages 126-136

  Stauber, Roland H ^a   Pavlakis, George N ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSACTIVATOR PROTEIN;

ARTICLE; CELL TRANSPORT; ENHANCER REGION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERMINAL REPEAT; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION; TRANSCRIPTION REGULATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; NES; RNA VIRUSES;

EID: 0032488243     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9400     Document Type: Article

References (63)

1. Afonina E., Stauber R., Pavlakis G. N. The human poly-A binding protein 1 shuttles between the nucleus and the cytoplasm. J. Biol. Chem. 273:1998;13015-13021.
2. Borer R. A., Lehner C. F., Eppenberger H. M., Nigg E. A. Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell. 56:1989;379-390.
3. Braddock M., Powell R., Blanchard A. D., Kingsman A. J., Kingsman S. M. HIV-1 TAR RNA-binding proteins control TAT activation of translation in Xenopus oocytes. FASEB J. 7:1993;214-222.
4. Carroll R., Peterlin B. M., Derse D. Inhibition of human immunodeficiency virus type 1 Tat activity by coexpression of heterologous trans activators. J. Virol. 66:1992;2000-2007.
5. Conant K., Garzino-Demo A., Nath A., McArthur J. C., Halliday W., Power C., Gallo R. C., Major E. O. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc. Natl. Acad. Sci. USA. 95:1998;3117-3121.
6. Cujec T. P., Cho H., Maldonado E., Meyer J., Rainberg D., Peterlin M. B. The human immunodeficiency virus transactivator protein Tat interacts with the RNA polymerase II holoenzyme. Mol. Cell. Biol. 17:1997a;1817-1823.
7. Cujec T. P., Okamoto H., Fujinaga K., Meyer J., Chamberlin H., Morgan D. O., Peterlin M. B. The HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II. Genes Dev. 11:1997b;2645-2657.
8. Cullen B. R. Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism. Cell. 46:1986;973-982.
9. D'Agostino D. M., Ciminale V., Pavlakis G. P., Chieco-Bianchi L. Intracellular trafficking of the human immunodeficiency virus type 1 Rev protein: Involvement of continued rRNA synthesis in nuclear retention. AIDS Res. Hum. Retroviruses. 11:1995;1063-1072.
10. Dobbelstein M., Roth J., Kimberly W. T., Levine A. J., Shenk T. Nuclear export of the E1B 55-kDa and E4-34-kDa adenoviral oncoproteins mediated by a rev-like signal sequence. EMBO J. 16:1997;4276-4284.
11. Ensoli B., Barillari G., Salahuddin S. Z., Gallo R. C., Wong-Staal F. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Proc. Natl. Acad. Sci. USA. 87:1990;3479-3483.
12. Ensoli B., Buonaguro L., Barillari G., Fiorelli V., Gendelman R., Morgan R. A., Wingfield P., Gallo R. C. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 67:1993;277-287.
13. Felber B. K. Regulation of mRNA expression in HIV-1 and other retroviruses. mRNA Metabolism and Post-Transcriptional Gene Regulation. 1997;Wiley-Liss, Inc, New York. p. 323-340.
14. Felber B. K., Drysdale C. M., Pavlakis G. N. Feedback regulation of human immunodeficiency virus type 1 expression by the Rev protein. J. Virol. 64:1990;3734-3741.
15. Frankel A. D., Bredt D. S., Pabo C. O. Tat protein from human immunodeficiency virus forms a metal-linked dimer. Science. 240:1988a;70-73.
16. Frankel A. D., Chen L., Cotter R. J., Pabo C. O. Dimerization of the tat protein from human immunodeficiency virus: A cysteine-rich peptide mimics the normal metal-linked dimer interface. Proc. Natl. Acad. Sci. USA. 85:1988b;6297-6300.
17. Gaynor R. B. Regulation of HIV-1 gene expression by the transactivator protein Tat. Transacting Functions of Human Retroviruses. 1995;Springer-Verlag, Berlin. p. 51-77.
18. Gibellini D., Bassini A., Pierpaoli S., Bertolaso L., Milani D., Capitani S., La Placa M., Zauli G. Extracellular HIV-1 Tat protein induces the rapid Ser133 phosphorylation and activation of CREB transcription factor in both Jurkat lymphoblastoid T cells and primary peripheral blood mononuclear cells. J. Immunol. 160:1998;3891-3898.
19. Giel-Pietraszuk M., Barciszewska M. Z., Mucha P., Rekowski P., Kupryszewski G., Barciszewski J. Interaction of HIV Tat model peptides with tRNA and 5S rRNA. Acta Biochim. Pol. 44:1997;591-600.
20. Görlich D., Mattaj I. W. Nucleocytoplasmic transport. Science. 271:1996;1513-1518.
21. Guichon-Mantle A., Lescop P., Christin-Maitre S., Loosfelt H., Perrot-Applanat M., Milgrom E. Nucleocytoplasmic shuttling of the progesterone receptor. EMBO J. 10:1991;3851-3859.
22. Harrich D., Ulich C., Garcia-Martinez L. F., Gaynor R. Tat is required for efficient HIV-1 reverse transcription. EMBO J. 16:1997;1224-1235.
23. Hauber J., Perkins A., Heimer E. P., Cullen B. R. Trans-activation of human immunodeficiency virus gene expression is mediated by nuclear events. Proc. Natl. Acad. Sci. USA. 84:1987;6364-6368.
24. Hope T. J., Klein N. P., Elder M. E., Parslow T. G. trans-dominant inhibition of human immunodeficiency virus type 1 Rev occurs through formation of inactive protein complexes. J. Virol. 66:1992;1849-1855.
25. Huang L. M., Joshi A., Willey R., Orenstein J., Jeang K. T. Human immunodeficiency viruses regulated by alternative trans-activators: Genetic evidence for a novel non-transcriptional function of Tat in virion infectivity. EMBO J. 13:1994;2886-2896.
26. Jones K. A. Taking a new TAK on Tat transactivation. Genes Dev. 11:1997;2593-2599.
27. Jones K. A., Peterlin M. B. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 63:1994;717-743.
28. Keen N., Churcher M., Karn J. Transfer of Tat and release of TAR RNA during activation of the human immunodeficiency virus type-1 transcription eleongation complex. EMBO J. 16:1997;5260-5272.
29. Keen N. J., Gait M. J., Karn J. Human immunodeficiency virus type-1 Tat is an integral component of the activated transcription -elongation complex. Proc. Natl. Acad. Sci. USA. 93:1996;2505-2510.
30. Lam W.-C., Seifert J. M., Amberger F., Graf C., Auer M., Millar D. P. Structural dynamics of HIV-1 Rev and its complexes with RRE and 5S-RNA. Biochemistry. 37:1998;1800-1809.
31. Lee S. L., Henry M., Silver P. A. A protein that shuttles between the nucleus and the cytoplasm is an important mediator of RNA export. Genes Dev. 10:1996;1233-1246.
32. Li Y.-P. Protein B23 is an important factor for the nucleolar localization of the human immunodeficiency virus protein Tat. J. Virol. 71:1997;4098-4102.
33. Luo Y., Madore S. J., Parslow T. G., Cullen B. R., Peterlin B. M. Functional analysis of interactions between Tat and thetrans. J. Virol. 67:1993;5617-5622.
34. Madan A. P., DeFranco D. Bidirectional transport of glucocorticoid receptor across the nuclear envelope. Proc. Natl. Acad. Sci. USA. 90:1993;3588-3592.
35. Mancebo H., Lee G., Flygare J., Tomassini J., Luu P., Zhu Y., Blau C., Hazuda D., Price D., Flores O. P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev. 11:1997;2633-2644.
36. Marasco W. A., Szilvay A. M., Kalland K. H., Helland D. G., Reyes H. M., Walter R. J. Spatial association of HIV-1 tat protein and the nucleolar transport protein B23 in stably transfected Jurkat T-cells. Arch. Virol. 139:1994;133-154.
37. Mavankal G., Du S. I., Oliver N., Sigman D., Gaynor R. B. HIV-1 and HIV-2 Tat proteins specifically interact with RNA polymerase II. Proc. Natl. Acad. Sci. USA. 93:1996;2089-2094.
38. Misteli T., Spector D. L. Application of the green fluorescent protein in cell biology and biotechnology. Nat. Biotech. 15:1997;961-964.
39. Modesti N., Garcia J., Debouck C., Peterlin M., Gaynor R. Trans-dominant Tat mutants with alterations in the basic domain inhibit HIV-1 gene expression. New Biol. 3:1991;759-768.
40. Nakielny S., Dreyfuss G. Nuclear export of proteins and RNAs. Curr. Opin. Cell Biol. 9:1997;420-429.
41. Nigg E. A. Nucleocytoplasmic transport: Signals, mechanisms and regulation. Nature. 386:1997;779-787.
42. Orsini M. J., Debouck C. M. Inhibition of human immunodeficiency virus type 1 and type 2 Tat function by transdominant Tat protein localized to both the nucleus and cytoplasm. J. Virol. 70:1996;8055-8063.
43. Pavlakis G. N. The molecular biology of human immunodeficiency virus type 1. DeVita V. T., Hellman S., Rosenberg S. A. AIDS: Biology, Diagnosis, Treatment and Prevention. 1997;45-74 Lippincott-Raven Publishers, Philadelphia.
44. Pearson L., Garcia J., Wu F., Modesti N., Nelson J., Gaynor R. A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat. Proc. Natl. Acad. Sci. USA. 87:1990;5079-5083.
45. Peterlin B. M. Transcriptional regulation of HIV. Hum. Retroviruses. 119:1990;153-162.
46. Rice A. P., Chan F. Tat protein of human immunodeficiency virus type 1 is a monomer when expressed in mammalian cells. Virology. 185:1991;451-454.
47. Rosen C. A., Sodroski J. G., Chun Goh W., Dayton A. I., Lippke J., Haseltine W. A. Post-transcriptional regulation accounts for the trans-activation of the human T-lymphotropic virus type III. Nature. 319:1986;555-559.
48. Roth J., Dobbelstein M., Freedman D. A., Shenk T., Levine A. J. Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J. 17:1998;554-564.
49. Sandri-Goldin R. M. ICP27 mediates HSV RNA export by shuttling through a leucine-rich nuclear export signal and binding viral intronless RNAs through an RGG motif. Genes Dev. 12:1998;868-879.
50. Schwartz S., Felber B. K., Benko D. M., Fenyö E. M., Pavlakis G. N. Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1. J. Virol. 64:1990;2519-2529.
51. Seeger M., Ferrell K., Frank R., Dubiel W. HIV-1 Tat inhibits the 20S proteasome and its 11S regulator-mediated activation. J. Biol. Chem. 13:1997;8145-8148.
52. Stauber R. H., Afonina E., Gulnik S., Erickson J., Pavlakis G. N. Analysis of intracellular trafficking and interactions of cytoplasmatic HIV-1 Rev mutants in living cells. Virology. 251:1998a;38-48.
53. Stauber R., Gaitanaris G. A., Pavlakis G. N. Analysis of trafficking of Rev and transdominant Rev proteins in living cells using Green Fluorescent Protein fusions: Transdominant Rev blocks the export of Rev from the nucleus to the cytoplasm. Virology. 213:1995;439-449.
54. Stauber R. H., Horie K., Carney P., Hudson E. A., Tarasova N. I., Gaitanaris G. A., Pavlakis G. N. Development and applications of enhanced green fluorescent protein mutants. BioTechniques. 24:1998b;462-471.
55. Szilvay A. M., Brokstad K. A., Kopperud R., Haukenes G., Kalland K.-H. Nuclear export of the human immunodeficiency virus type 1 nucleocytoplasmic shuttle protein Rev is mediated by its activation domain and is blocked by transdominant negative mutants. J. Virol. 69:1995;3315-3323.
56. Thomas S. L., Oft M., Jaksche H., Casari G., Heger P., Dobrovnik M., Bevec D., Hauber J. Functional analysis of the human immunodeficiency virus type 1 Rev protein oligomerization interface. J. Virol. 72:1998;2935-2944.
57. Towatari M., Kanei Y., Saito H., Hamaguchi M. Hematopoietic transcription factor GATA-2 activates transcription from HIV-1 long terminal repeat. Aids. 12:1998;253-259.
58. Venkatesan S., Gerstberger S. M., Park H., Holland S. M., Nam Y. S. Human immunodeficiency virus type-1 Rev activation can be achieved without Rev-responsive element RNA if Rev is directed to the target as a Rev/MS2 fusion protein which tethers the MS2 operator RNA. J. Virol. 66:1992;7469-7480.
59. Viscidi R. P., Mayor K., Lederman H. M., Frankel A. D. Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1. Science. 246:1989;1606-1608.
60. Waszak G. A., Hasler J. M., McQuade T. J., Tarpley W. G., Deibel M. R. Purification of an active monomeric recombinant HIV-1 trans-activator. Protein Expr. Purif. 3:1992;126-133.
61. Wei P., Garber M. E., Fang S.-M., Fischer W. H., Jones K. A. A novel CDK9-associated C-type cyclin interacts directly with the HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell. 92:1998;451-462.
62. Wright C. M., Felber B. K., Paskalis H., Pavlakis G. N. Expression and characterization of thetrans. Science. 234:1986;988-992.
63. Zauli G., La Placa M., Vignoli M., Re M. C., Gibellini D., Furlini G., Milani D., Marchisio M., Mazzoni M., Capitani S. An autocrine loop of HIV type-1 Tat protein responsible for the improved survival/proliferation capacity of permanently Tat-transfected cells and required for optimal HIV-1 LTR transactivating activity. J. Acquir. Immune Defic. Syndr. Human Retrovirol. 10:1995;306-316.